Genfit SA (GNFT)
4.20
-0.04
(-0.94%)
USD |
NASDAQ |
Nov 22, 16:00
4.21
+0.01
(+0.24%)
After-Hours: 20:00
Genfit Total Return Price: 4.20 for Nov. 22, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
November 22, 2024 | 4.20 |
November 21, 2024 | 4.24 |
November 20, 2024 | 4.31 |
November 19, 2024 | 4.263 |
November 18, 2024 | 4.37 |
November 15, 2024 | 4.50 |
November 14, 2024 | 4.535 |
November 13, 2024 | 5.21 |
November 12, 2024 | 5.212 |
November 11, 2024 | 5.23 |
November 08, 2024 | 5.23 |
November 07, 2024 | 5.71 |
November 06, 2024 | 5.596 |
November 05, 2024 | 5.79 |
November 04, 2024 | 5.76 |
November 01, 2024 | 5.88 |
October 31, 2024 | 5.85 |
October 30, 2024 | 5.85 |
October 29, 2024 | 5.51 |
October 28, 2024 | 5.51 |
October 25, 2024 | 5.50 |
October 24, 2024 | 5.59 |
October 23, 2024 | 5.70 |
October 22, 2024 | 5.995 |
October 21, 2024 | 5.945 |
Date | Value |
---|---|
October 18, 2024 | 5.94 |
October 17, 2024 | 6.33 |
October 16, 2024 | 6.28 |
October 15, 2024 | 5.91 |
October 14, 2024 | 6.11 |
October 11, 2024 | 6.06 |
October 10, 2024 | 5.541 |
October 09, 2024 | 5.55 |
October 08, 2024 | 5.585 |
October 07, 2024 | 5.46 |
October 04, 2024 | 5.386 |
October 03, 2024 | 5.30 |
October 02, 2024 | 5.146 |
October 01, 2024 | 5.063 |
September 30, 2024 | 5.97 |
September 27, 2024 | 5.70 |
September 26, 2024 | 5.61 |
September 25, 2024 | 5.38 |
September 24, 2024 | 5.28 |
September 23, 2024 | 4.99 |
September 20, 2024 | 4.84 |
September 19, 2024 | 4.19 |
September 18, 2024 | 4.340 |
September 17, 2024 | 4.23 |
September 16, 2024 | 4.135 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
2.97
Minimum
Oct 25 2023
22.00
Maximum
May 11 2020
5.423
Average
4.115
Median
Total Return Price Benchmarks
Edap TMS SA | 2.47 |
DBV Technologies SA | 0.469 |
Cellectis SA | 1.87 |
Adaptimmune Therapeutics PLC | 0.6616 |
Akari Therapeutics PLC | 1.30 |